| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 18 | 2020 | 787 | 1.920 |
Why?
|
| Energy Metabolism | 21 | 2006 | 992 | 1.150 |
Why?
|
| Sucking Behavior | 4 | 2012 | 20 | 0.910 |
Why?
|
| Enteral Nutrition | 6 | 2014 | 316 | 0.900 |
Why?
|
| Milk, Human | 22 | 2012 | 277 | 0.880 |
Why?
|
| Myopia | 2 | 2021 | 194 | 0.850 |
Why?
|
| Lighting | 1 | 2021 | 27 | 0.790 |
Why?
|
| Infant, Newborn | 71 | 2020 | 8223 | 0.760 |
Why?
|
| Body Composition | 22 | 2005 | 595 | 0.760 |
Why?
|
| Lactation | 13 | 2007 | 210 | 0.730 |
Why?
|
| Body Weight | 29 | 2014 | 1293 | 0.720 |
Why?
|
| Adipose Tissue | 20 | 2006 | 769 | 0.710 |
Why?
|
| Breast Feeding | 20 | 2000 | 239 | 0.680 |
Why?
|
| Isoflavones | 4 | 2013 | 72 | 0.650 |
Why?
|
| Obesity | 17 | 2014 | 2884 | 0.630 |
Why?
|
| Swine | 11 | 2008 | 1541 | 0.620 |
Why?
|
| Feeding Behavior | 6 | 2012 | 808 | 0.600 |
Why?
|
| Mothers | 1 | 2020 | 410 | 0.590 |
Why?
|
| beta-Glucans | 3 | 2013 | 34 | 0.560 |
Why?
|
| Parenting | 1 | 2020 | 345 | 0.560 |
Why?
|
| Self Concept | 2 | 2016 | 211 | 0.550 |
Why?
|
| Minority Groups | 3 | 2016 | 322 | 0.530 |
Why?
|
| Postpartum Period | 5 | 2003 | 259 | 0.520 |
Why?
|
| Stress, Psychological | 2 | 2020 | 1000 | 0.490 |
Why?
|
| Infant Food | 10 | 2010 | 89 | 0.480 |
Why?
|
| Indians, North American | 5 | 1997 | 87 | 0.460 |
Why?
|
| Energy Intake | 12 | 2004 | 515 | 0.460 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2017 | 208 | 0.450 |
Why?
|
| Basal Metabolism | 9 | 2003 | 88 | 0.450 |
Why?
|
| Female | 167 | 2020 | 141928 | 0.450 |
Why?
|
| Dietary Supplements | 5 | 2013 | 558 | 0.440 |
Why?
|
| Infant | 74 | 2020 | 13310 | 0.440 |
Why?
|
| Lactose | 3 | 2005 | 63 | 0.440 |
Why?
|
| Deglutition | 2 | 2012 | 171 | 0.440 |
Why?
|
| Pacifiers | 1 | 2012 | 4 | 0.430 |
Why?
|
| Rett Syndrome | 4 | 2009 | 262 | 0.430 |
Why?
|
| Growth | 9 | 2000 | 117 | 0.400 |
Why?
|
| Lactase | 3 | 2010 | 38 | 0.390 |
Why?
|
| Postmenopause | 2 | 2010 | 378 | 0.390 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 2000 | 97 | 0.390 |
Why?
|
| Gestational Age | 14 | 2018 | 1069 | 0.380 |
Why?
|
| Gastrointestinal Contents | 1 | 2010 | 12 | 0.380 |
Why?
|
| Intestinal Mucosa | 3 | 2005 | 1081 | 0.380 |
Why?
|
| Eating | 4 | 2010 | 421 | 0.370 |
Why?
|
| Humans | 210 | 2021 | 261506 | 0.370 |
Why?
|
| Motor Skills | 1 | 2011 | 107 | 0.370 |
Why?
|
| Adolescent | 66 | 2019 | 31252 | 0.360 |
Why?
|
| Child | 69 | 2019 | 29154 | 0.360 |
Why?
|
| Male | 127 | 2020 | 123000 | 0.360 |
Why?
|
| Child Development | 6 | 2012 | 255 | 0.360 |
Why?
|
| Body Mass Index | 12 | 2016 | 2203 | 0.350 |
Why?
|
| Bone Density | 3 | 2009 | 476 | 0.350 |
Why?
|
| Infant Formula | 2 | 2012 | 91 | 0.350 |
Why?
|
| Adipocytes | 7 | 2005 | 305 | 0.350 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 54 | 0.350 |
Why?
|
| Enterocolitis, Necrotizing | 6 | 2014 | 223 | 0.350 |
Why?
|
| Betaine | 1 | 2009 | 27 | 0.340 |
Why?
|
| Folic Acid | 2 | 2009 | 349 | 0.340 |
Why?
|
| Refraction, Ocular | 2 | 2021 | 289 | 0.340 |
Why?
|
| Probiotics | 1 | 2012 | 228 | 0.330 |
Why?
|
| Thinness | 2 | 2014 | 82 | 0.330 |
Why?
|
| Birth Weight | 9 | 2007 | 374 | 0.330 |
Why?
|
| Pregnancy | 26 | 2018 | 7573 | 0.330 |
Why?
|
| Child, Preschool | 55 | 2017 | 16273 | 0.320 |
Why?
|
| Metabolic Syndrome | 4 | 2005 | 353 | 0.320 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 34 | 0.320 |
Why?
|
| Receptors, Purinergic P1 | 2 | 1997 | 25 | 0.320 |
Why?
|
| Cerebrum | 1 | 2008 | 44 | 0.310 |
Why?
|
| Umbilical Arteries | 3 | 2004 | 59 | 0.300 |
Why?
|
| Infant, Premature, Diseases | 3 | 2014 | 245 | 0.300 |
Why?
|
| Infant, Very Low Birth Weight | 5 | 2014 | 165 | 0.280 |
Why?
|
| Nutritional Requirements | 7 | 2016 | 185 | 0.270 |
Why?
|
| Pregnancy in Adolescence | 1 | 2006 | 58 | 0.270 |
Why?
|
| Milk Banks | 1 | 2005 | 3 | 0.270 |
Why?
|
| Depression, Postpartum | 1 | 2006 | 45 | 0.270 |
Why?
|
| Cholesterol | 2 | 2008 | 658 | 0.270 |
Why?
|
| Minerals | 3 | 2000 | 71 | 0.270 |
Why?
|
| Prospective Studies | 26 | 2019 | 12873 | 0.260 |
Why?
|
| Bottle Feeding | 5 | 2011 | 36 | 0.260 |
Why?
|
| Lenses | 1 | 2004 | 14 | 0.260 |
Why?
|
| Behavior, Animal | 1 | 2008 | 709 | 0.240 |
Why?
|
| Catheterization, Peripheral | 2 | 2004 | 158 | 0.240 |
Why?
|
| Adult | 64 | 2020 | 77950 | 0.240 |
Why?
|
| Body Water | 9 | 2003 | 132 | 0.230 |
Why?
|
| Animal Nutritional Physiological Phenomena | 2 | 2008 | 59 | 0.230 |
Why?
|
| Texas | 18 | 2017 | 6311 | 0.230 |
Why?
|
| School Health Services | 4 | 2016 | 109 | 0.230 |
Why?
|
| Nitrogen | 6 | 2001 | 162 | 0.230 |
Why?
|
| Weaning | 3 | 1997 | 45 | 0.230 |
Why?
|
| Diet | 8 | 2016 | 1440 | 0.220 |
Why?
|
| Heart Transplantation | 5 | 2008 | 908 | 0.220 |
Why?
|
| Graft Rejection | 5 | 2012 | 834 | 0.220 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2012 | 199 | 0.220 |
Why?
|
| Anthropometry | 9 | 2003 | 269 | 0.210 |
Why?
|
| Menopause | 2 | 2013 | 159 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2014 | 830 | 0.210 |
Why?
|
| Double-Blind Method | 9 | 2019 | 2588 | 0.210 |
Why?
|
| Macaca mulatta | 2 | 2021 | 717 | 0.210 |
Why?
|
| Potassium | 6 | 2000 | 329 | 0.210 |
Why?
|
| Mass Screening | 5 | 2016 | 1509 | 0.200 |
Why?
|
| Models, Biological | 8 | 2002 | 3254 | 0.200 |
Why?
|
| Sensory Deprivation | 1 | 2021 | 35 | 0.200 |
Why?
|
| Eyeglasses | 1 | 2021 | 32 | 0.200 |
Why?
|
| Motor Activity | 3 | 2011 | 693 | 0.200 |
Why?
|
| Accommodation, Ocular | 1 | 2021 | 33 | 0.200 |
Why?
|
| Depth Perception | 1 | 2021 | 34 | 0.200 |
Why?
|
| Contact Lenses | 1 | 2021 | 45 | 0.190 |
Why?
|
| Weight Gain | 3 | 2003 | 464 | 0.190 |
Why?
|
| Vision, Binocular | 1 | 2021 | 71 | 0.190 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2012 | 74 | 0.190 |
Why?
|
| Reproduction | 1 | 2003 | 253 | 0.190 |
Why?
|
| Mucin-1 | 3 | 2010 | 127 | 0.190 |
Why?
|
| Physical Exertion | 2 | 1999 | 113 | 0.190 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2009 | 253 | 0.190 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2008 | 343 | 0.190 |
Why?
|
| Calcification, Physiologic | 1 | 2000 | 56 | 0.190 |
Why?
|
| Sleep | 3 | 2013 | 413 | 0.180 |
Why?
|
| Tuberculosis | 2 | 2016 | 548 | 0.180 |
Why?
|
| Circadian Rhythm | 2 | 2021 | 330 | 0.180 |
Why?
|
| Strabismus | 1 | 2021 | 213 | 0.180 |
Why?
|
| Intestine, Small | 2 | 2005 | 499 | 0.180 |
Why?
|
| beta-Galactosidase | 2 | 1998 | 211 | 0.180 |
Why?
|
| Mother-Child Relations | 1 | 2020 | 81 | 0.180 |
Why?
|
| Myopia, Degenerative | 1 | 2019 | 6 | 0.180 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2019 | 15 | 0.180 |
Why?
|
| Visual Cortex | 1 | 2021 | 136 | 0.180 |
Why?
|
| Colitis, Ulcerative | 2 | 2014 | 268 | 0.170 |
Why?
|
| Plant Extracts | 2 | 2012 | 215 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2009 | 244 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 6 | 2008 | 1237 | 0.170 |
Why?
|
| Puberty | 2 | 1999 | 104 | 0.170 |
Why?
|
| Lung Transplantation | 3 | 2012 | 359 | 0.170 |
Why?
|
| Eye | 1 | 2021 | 301 | 0.170 |
Why?
|
| Animals, Suckling | 2 | 1999 | 54 | 0.170 |
Why?
|
| Longitudinal Studies | 15 | 2010 | 1945 | 0.170 |
Why?
|
| Niacin | 2 | 2011 | 61 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2020 | 298 | 0.170 |
Why?
|
| Oxygen Consumption | 4 | 2003 | 401 | 0.170 |
Why?
|
| Fenofibrate | 2 | 2011 | 57 | 0.170 |
Why?
|
| Pertussis Toxin | 1 | 2018 | 57 | 0.170 |
Why?
|
| Severity of Illness Index | 12 | 2014 | 4320 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2011 | 192 | 0.160 |
Why?
|
| Risk Factors | 26 | 2016 | 17523 | 0.160 |
Why?
|
| Age Factors | 18 | 2014 | 5377 | 0.160 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2018 | 37 | 0.160 |
Why?
|
| Whooping Cough | 1 | 2018 | 62 | 0.160 |
Why?
|
| Time Factors | 20 | 2014 | 12926 | 0.160 |
Why?
|
| Antibodies, Bacterial | 3 | 2018 | 380 | 0.160 |
Why?
|
| Insulin | 6 | 2013 | 1454 | 0.150 |
Why?
|
| Poverty | 4 | 2016 | 471 | 0.150 |
Why?
|
| Exercise | 7 | 2016 | 1183 | 0.150 |
Why?
|
| Dietary Fats | 5 | 2006 | 339 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 7 | 2007 | 182 | 0.150 |
Why?
|
| Cardiac Output | 2 | 1988 | 194 | 0.150 |
Why?
|
| Calorimetry, Indirect | 5 | 2003 | 60 | 0.150 |
Why?
|
| Students | 2 | 2016 | 324 | 0.150 |
Why?
|
| Natriuretic Agents | 2 | 2007 | 31 | 0.150 |
Why?
|
| Aging | 5 | 2007 | 1582 | 0.150 |
Why?
|
| Reference Values | 9 | 2014 | 1099 | 0.150 |
Why?
|
| Cross-Sectional Studies | 11 | 2014 | 4314 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2000 | 619 | 0.140 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 26 | 0.140 |
Why?
|
| Sex Reassignment Procedures | 1 | 2016 | 19 | 0.140 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2010 | 161 | 0.140 |
Why?
|
| Splanchnic Circulation | 2 | 2014 | 53 | 0.140 |
Why?
|
| Breath Tests | 6 | 2009 | 177 | 0.140 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2014 | 100 | 0.140 |
Why?
|
| Placebos | 5 | 2013 | 437 | 0.140 |
Why?
|
| Analysis of Variance | 11 | 2019 | 2307 | 0.140 |
Why?
|
| Biomarkers | 8 | 2014 | 5047 | 0.140 |
Why?
|
| Cornea | 1 | 2021 | 638 | 0.140 |
Why?
|
| Regression Analysis | 12 | 2007 | 1546 | 0.140 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2009 | 291 | 0.140 |
Why?
|
| Hospitals, Pediatric | 4 | 2014 | 773 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 461 | 0.130 |
Why?
|
| Calorimetry | 5 | 2006 | 62 | 0.130 |
Why?
|
| Animals, Newborn | 5 | 2008 | 1338 | 0.130 |
Why?
|
| Predictive Value of Tests | 13 | 2014 | 4892 | 0.130 |
Why?
|
| Proteins | 3 | 2004 | 1963 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 117 | 0.130 |
Why?
|
| Blood Glucose | 5 | 2008 | 1244 | 0.130 |
Why?
|
| Community Health Services | 1 | 2016 | 126 | 0.130 |
Why?
|
| Staphylococcal Infections | 3 | 2012 | 672 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 1998 | 629 | 0.130 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 230 | 0.120 |
Why?
|
| Hyperglycemia | 2 | 2008 | 333 | 0.120 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 196 | 0.120 |
Why?
|
| Lactose Intolerance | 3 | 2005 | 11 | 0.120 |
Why?
|
| Health Education | 1 | 2016 | 309 | 0.120 |
Why?
|
| Blood Pressure | 5 | 2012 | 1467 | 0.120 |
Why?
|
| Oxygen | 4 | 2014 | 754 | 0.120 |
Why?
|
| Swine Diseases | 3 | 1999 | 41 | 0.120 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 5687 | 0.120 |
Why?
|
| Residence Characteristics | 2 | 2014 | 348 | 0.120 |
Why?
|
| Animals | 28 | 2021 | 59536 | 0.120 |
Why?
|
| Gastroenterology | 1 | 2017 | 195 | 0.120 |
Why?
|
| Catecholamines | 2 | 1999 | 101 | 0.120 |
Why?
|
| Absorptiometry, Photon | 5 | 2002 | 239 | 0.120 |
Why?
|
| Mitochondrial Diseases | 2 | 2006 | 137 | 0.120 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 58 | 0.120 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 112 | 0.120 |
Why?
|
| Lipid Metabolism | 4 | 2006 | 483 | 0.120 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 30 | 0.120 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 84 | 0.120 |
Why?
|
| Urban Population | 2 | 2014 | 269 | 0.120 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2014 | 173 | 0.120 |
Why?
|
| Blood Urea Nitrogen | 2 | 2010 | 95 | 0.110 |
Why?
|
| Methotrexate | 1 | 2017 | 999 | 0.110 |
Why?
|
| Guinea Pigs | 2 | 1985 | 241 | 0.110 |
Why?
|
| Larynx, Artificial | 1 | 2013 | 43 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 108 | 0.110 |
Why?
|
| Forced Expiratory Volume | 2 | 2012 | 314 | 0.110 |
Why?
|
| Glutamate Decarboxylase | 1 | 2013 | 44 | 0.110 |
Why?
|
| Indomethacin | 3 | 2003 | 91 | 0.110 |
Why?
|
| Respiratory Function Tests | 2 | 2011 | 318 | 0.110 |
Why?
|
| C-Peptide | 1 | 2013 | 107 | 0.110 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2014 | 80 | 0.110 |
Why?
|
| Prevalence | 5 | 2021 | 3260 | 0.110 |
Why?
|
| Mexico | 5 | 1997 | 259 | 0.110 |
Why?
|
| Larynx | 1 | 2013 | 134 | 0.110 |
Why?
|
| Adiposity | 1 | 2014 | 237 | 0.110 |
Why?
|
| Retrospective Studies | 28 | 2017 | 37905 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 5 | 2005 | 181 | 0.110 |
Why?
|
| Adiponectin | 2 | 2011 | 163 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 125 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 242 | 0.110 |
Why?
|
| Carbon Isotopes | 3 | 2009 | 333 | 0.110 |
Why?
|
| Treatment Outcome | 22 | 2014 | 32848 | 0.100 |
Why?
|
| Health Promotion | 1 | 2016 | 502 | 0.100 |
Why?
|
| Nutritional Status | 2 | 2011 | 337 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2017 | 899 | 0.100 |
Why?
|
| Heart Function Tests | 1 | 2011 | 73 | 0.100 |
Why?
|
| Intestinal Absorption | 3 | 2005 | 211 | 0.100 |
Why?
|
| Islets of Langerhans | 1 | 2013 | 229 | 0.100 |
Why?
|
| Linear Models | 2 | 2012 | 1085 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 217 | 0.100 |
Why?
|
| Water Microbiology | 1 | 1991 | 22 | 0.100 |
Why?
|
| Primary Health Care | 2 | 2017 | 787 | 0.100 |
Why?
|
| Water Supply | 1 | 1991 | 24 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 44 | 0.100 |
Why?
|
| Meningitis, Haemophilus | 2 | 1988 | 34 | 0.100 |
Why?
|
| Echocardiography | 7 | 2011 | 1182 | 0.100 |
Why?
|
| Lactulose | 3 | 1998 | 38 | 0.100 |
Why?
|
| Fractures, Spontaneous | 1 | 2012 | 84 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 1303 | 0.100 |
Why?
|
| Skinfold Thickness | 5 | 2000 | 39 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 598 | 0.100 |
Why?
|
| Phytoestrogens | 1 | 2010 | 26 | 0.100 |
Why?
|
| Critical Illness | 4 | 2001 | 714 | 0.100 |
Why?
|
| Tracheostomy | 1 | 2013 | 243 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2013 | 258 | 0.100 |
Why?
|
| Weight Reduction Programs | 1 | 2012 | 78 | 0.100 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2010 | 17 | 0.090 |
Why?
|
| Sepsis | 6 | 2005 | 652 | 0.090 |
Why?
|
| Cardiac Output, Low | 2 | 2007 | 81 | 0.090 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 18 | 0.090 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 1225 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 136 | 0.090 |
Why?
|
| Cardiac Catheterization | 4 | 2011 | 687 | 0.090 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 144 | 0.090 |
Why?
|
| Emphysema | 1 | 2011 | 87 | 0.090 |
Why?
|
| Follow-Up Studies | 16 | 2014 | 14889 | 0.090 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 79 | 0.090 |
Why?
|
| Gastric Emptying | 1 | 2010 | 94 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 148 | 0.090 |
Why?
|
| Intestines | 1 | 2014 | 686 | 0.090 |
Why?
|
| Mouth | 1 | 2011 | 122 | 0.090 |
Why?
|
| Heart Failure | 4 | 2009 | 2516 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 76 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2011 | 235 | 0.090 |
Why?
|
| beta-Fructofuranosidase | 1 | 2009 | 4 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 227 | 0.090 |
Why?
|
| Positive-Pressure Respiration | 2 | 2001 | 116 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 447 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2009 | 10 | 0.090 |
Why?
|
| Facial Nerve Diseases | 1 | 2009 | 21 | 0.090 |
Why?
|
| Hypertension | 6 | 2011 | 1503 | 0.090 |
Why?
|
| Algorithms | 3 | 2017 | 3890 | 0.090 |
Why?
|
| Heart Rate | 5 | 2007 | 737 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 22 | 0.090 |
Why?
|
| Neuroendocrine Cells | 1 | 2009 | 14 | 0.090 |
Why?
|
| Body Height | 10 | 2000 | 231 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2013 | 576 | 0.090 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 2009 | 31 | 0.090 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 364 | 0.090 |
Why?
|
| Defibrillators | 1 | 2009 | 25 | 0.090 |
Why?
|
| Sucrose | 1 | 2009 | 64 | 0.090 |
Why?
|
| Feces | 2 | 2010 | 770 | 0.080 |
Why?
|
| Respiration, Artificial | 4 | 2001 | 577 | 0.080 |
Why?
|
| Hypolipidemic Agents | 2 | 2011 | 190 | 0.080 |
Why?
|
| Animal Feed | 2 | 2008 | 81 | 0.080 |
Why?
|
| Leptin | 5 | 2005 | 295 | 0.080 |
Why?
|
| Behavior Therapy | 1 | 2012 | 298 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 603 | 0.080 |
Why?
|
| Osteomyelitis | 1 | 2012 | 236 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 241 | 0.080 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 45 | 0.080 |
Why?
|
| Statistics as Topic | 3 | 2004 | 445 | 0.080 |
Why?
|
| Facial Paralysis | 1 | 2009 | 60 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 1209 | 0.080 |
Why?
|
| Moxalactam | 1 | 1988 | 24 | 0.080 |
Why?
|
| Lung Diseases | 2 | 2010 | 717 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2018 | 124 | 0.080 |
Why?
|
| Chloramphenicol | 1 | 1988 | 28 | 0.080 |
Why?
|
| Electric Countershock | 1 | 2009 | 71 | 0.080 |
Why?
|
| Retinal Neoplasms | 1 | 2010 | 144 | 0.080 |
Why?
|
| Retinoblastoma | 1 | 2010 | 200 | 0.080 |
Why?
|
| Milk Substitutes | 1 | 2008 | 7 | 0.080 |
Why?
|
| Ampicillin | 1 | 1988 | 58 | 0.080 |
Why?
|
| Hypoxia | 2 | 1989 | 443 | 0.080 |
Why?
|
| Lung | 2 | 2010 | 3151 | 0.080 |
Why?
|
| Risk | 4 | 2012 | 1972 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2006 | 157 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 2009 | 137 | 0.080 |
Why?
|
| Social Class | 3 | 2017 | 310 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2011 | 235 | 0.080 |
Why?
|
| Attitude to Health | 1 | 2011 | 465 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2012 | 644 | 0.080 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 174 | 0.080 |
Why?
|
| Patient Compliance | 3 | 1997 | 667 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 139 | 0.080 |
Why?
|
| DNA, Mitochondrial | 2 | 2006 | 311 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2014 | 6100 | 0.080 |
Why?
|
| Air Ambulances | 1 | 2007 | 28 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2010 | 661 | 0.080 |
Why?
|
| Dogs | 3 | 2006 | 1155 | 0.080 |
Why?
|
| Virus Activation | 2 | 2013 | 228 | 0.080 |
Why?
|
| Postoperative Complications | 6 | 2014 | 5542 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2011 | 351 | 0.080 |
Why?
|
| Vitamin D | 1 | 2009 | 261 | 0.070 |
Why?
|
| F2-Isoprostanes | 1 | 2007 | 28 | 0.070 |
Why?
|
| Heart Block | 1 | 2007 | 48 | 0.070 |
Why?
|
| Deuterium | 5 | 2003 | 111 | 0.070 |
Why?
|
| Heart Defects, Congenital | 3 | 2008 | 1697 | 0.070 |
Why?
|
| Seizures | 2 | 2010 | 989 | 0.070 |
Why?
|
| Immunoassay | 3 | 2008 | 216 | 0.070 |
Why?
|
| Transportation of Patients | 1 | 2007 | 59 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 1988 | 180 | 0.070 |
Why?
|
| Life Style | 2 | 2011 | 612 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2009 | 234 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 399 | 0.070 |
Why?
|
| Gene Products, vpr | 1 | 2006 | 24 | 0.070 |
Why?
|
| Myelin Sheath | 1 | 2007 | 149 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 1988 | 151 | 0.070 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 29 | 0.070 |
Why?
|
| Calcium | 4 | 2009 | 1537 | 0.070 |
Why?
|
| Diet, Fat-Restricted | 1 | 2006 | 56 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2007 | 93 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 4938 | 0.070 |
Why?
|
| Organ Size | 1 | 2008 | 690 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2007 | 127 | 0.070 |
Why?
|
| Pulmonary Surfactants | 2 | 1998 | 50 | 0.070 |
Why?
|
| Hydrogen | 2 | 1985 | 58 | 0.070 |
Why?
|
| Chemokines, CC | 1 | 2005 | 36 | 0.070 |
Why?
|
| Middle Aged | 22 | 2013 | 86204 | 0.070 |
Why?
|
| Rural Population | 4 | 1996 | 281 | 0.070 |
Why?
|
| Developmental Disabilities | 2 | 2007 | 674 | 0.070 |
Why?
|
| Premature Birth | 1 | 2011 | 407 | 0.070 |
Why?
|
| Insulin Infusion Systems | 1 | 2005 | 53 | 0.070 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 1985 | 94 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 221 | 0.070 |
Why?
|
| Cachexia | 1 | 2007 | 161 | 0.070 |
Why?
|
| Tetrahydrofolates | 1 | 2005 | 21 | 0.070 |
Why?
|
| Simethicone | 1 | 1985 | 2 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2012 | 4971 | 0.070 |
Why?
|
| Stroke Volume | 5 | 2011 | 577 | 0.070 |
Why?
|
| Breeding | 2 | 1997 | 29 | 0.070 |
Why?
|
| Child Health Services | 2 | 2016 | 82 | 0.070 |
Why?
|
| Age of Onset | 4 | 2014 | 827 | 0.070 |
Why?
|
| Helicobacter pylori | 2 | 1994 | 1295 | 0.070 |
Why?
|
| Cardiomyopathies | 3 | 2007 | 610 | 0.070 |
Why?
|
| Neutrophils | 3 | 2006 | 835 | 0.070 |
Why?
|
| Helicobacter Infections | 2 | 1994 | 1216 | 0.070 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2005 | 13 | 0.070 |
Why?
|
| Silicones | 1 | 1985 | 54 | 0.070 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2006 | 186 | 0.070 |
Why?
|
| Cryopreservation | 1 | 2006 | 175 | 0.070 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2005 | 12 | 0.060 |
Why?
|
| Prognosis | 8 | 2013 | 21713 | 0.060 |
Why?
|
| Cytokines | 4 | 2014 | 2809 | 0.060 |
Why?
|
| Food, Fortified | 1 | 1985 | 95 | 0.060 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2004 | 21 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2010 | 363 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 925 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2005 | 69 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2006 | 144 | 0.060 |
Why?
|
| Catheterization | 2 | 2005 | 410 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 120 | 0.060 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2004 | 25 | 0.060 |
Why?
|
| Digestion | 1 | 2005 | 55 | 0.060 |
Why?
|
| Brain | 3 | 2009 | 4113 | 0.060 |
Why?
|
| Logistic Models | 6 | 2017 | 3441 | 0.060 |
Why?
|
| Models, Statistical | 3 | 2000 | 1171 | 0.060 |
Why?
|
| Nutrition Surveys | 4 | 2011 | 295 | 0.060 |
Why?
|
| Environment | 1 | 2005 | 190 | 0.060 |
Why?
|
| Odds Ratio | 4 | 2014 | 2316 | 0.060 |
Why?
|
| Platelet Transfusion | 1 | 2005 | 156 | 0.060 |
Why?
|
| Adenoidectomy | 1 | 2005 | 63 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 317 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 301 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 235 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2000 | 495 | 0.060 |
Why?
|
| Otitis Media with Effusion | 1 | 2004 | 20 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2011 | 945 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2009 | 358 | 0.060 |
Why?
|
| Empyema, Pleural | 1 | 2004 | 48 | 0.060 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.060 |
Why?
|
| Developing Countries | 3 | 2014 | 315 | 0.060 |
Why?
|
| Ultrasonography | 6 | 2013 | 1863 | 0.060 |
Why?
|
| Arginine Vasopressin | 1 | 2004 | 60 | 0.060 |
Why?
|
| Neuromuscular Diseases | 1 | 2004 | 63 | 0.060 |
Why?
|
| Body Constitution | 3 | 1995 | 35 | 0.060 |
Why?
|
| Recurrence | 3 | 2010 | 4758 | 0.060 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 52 | 0.060 |
Why?
|
| Dietary Proteins | 3 | 2001 | 241 | 0.060 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2003 | 3 | 0.060 |
Why?
|
| Antigens | 1 | 2005 | 292 | 0.060 |
Why?
|
| Seasons | 2 | 2003 | 340 | 0.060 |
Why?
|
| Tonsillectomy | 1 | 2005 | 102 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 248 | 0.060 |
Why?
|
| Perfusion | 1 | 2005 | 293 | 0.060 |
Why?
|
| Digoxin | 1 | 2003 | 63 | 0.060 |
Why?
|
| Interleukin-6 | 3 | 2005 | 1038 | 0.060 |
Why?
|
| JC Virus | 1 | 2003 | 43 | 0.060 |
Why?
|
| Terbutaline | 2 | 1993 | 27 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 2796 | 0.060 |
Why?
|
| Virus Shedding | 1 | 2003 | 88 | 0.060 |
Why?
|
| Transposition of Great Vessels | 1 | 2004 | 124 | 0.060 |
Why?
|
| Propranolol | 1 | 2003 | 156 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 1547 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2004 | 435 | 0.060 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2004 | 209 | 0.060 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2003 | 84 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2000 | 875 | 0.050 |
Why?
|
| DNA, Viral | 3 | 2013 | 694 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3101 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 2017 | 1382 | 0.050 |
Why?
|
| Intestinal Perforation | 1 | 2003 | 102 | 0.050 |
Why?
|
| DiGeorge Syndrome | 1 | 2003 | 77 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2003 | 122 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2003 | 137 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 167 | 0.050 |
Why?
|
| Meningococcal Infections | 1 | 2002 | 21 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 241 | 0.050 |
Why?
|
| BK Virus | 1 | 2003 | 123 | 0.050 |
Why?
|
| Rest | 2 | 1999 | 71 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 151 | 0.050 |
Why?
|
| Incidence | 6 | 2012 | 5673 | 0.050 |
Why?
|
| Survival Analysis | 7 | 2014 | 9180 | 0.050 |
Why?
|
| Hypocotyl | 2 | 2012 | 5 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 226 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2003 | 128 | 0.050 |
Why?
|
| Multivariate Analysis | 7 | 2011 | 4298 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2016 | 597 | 0.050 |
Why?
|
| Computers | 2 | 1983 | 141 | 0.050 |
Why?
|
| Postpericardiotomy Syndrome | 1 | 2001 | 3 | 0.050 |
Why?
|
| Alleles | 1 | 2008 | 2437 | 0.050 |
Why?
|
| Paracentesis | 1 | 2001 | 18 | 0.050 |
Why?
|
| Myocardium | 1 | 2008 | 1313 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2001 | 42 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2002 | 128 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2021 | 62 | 0.050 |
Why?
|
| Colon | 1 | 1985 | 670 | 0.050 |
Why?
|
| Sex Factors | 5 | 2013 | 2139 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2005 | 228 | 0.050 |
Why?
|
| Adolescent Health Services | 2 | 2000 | 36 | 0.050 |
Why?
|
| Premedication | 1 | 2001 | 135 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 747 | 0.050 |
Why?
|
| Cohort Studies | 7 | 2009 | 9244 | 0.050 |
Why?
|
| Drug Therapy | 1 | 1982 | 205 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 4367 | 0.050 |
Why?
|
| Pediatrics | 3 | 2017 | 1141 | 0.050 |
Why?
|
| Parenteral Nutrition | 2 | 2001 | 207 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2002 | 441 | 0.050 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 134 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 577 | 0.050 |
Why?
|
| Quality of Life | 2 | 2013 | 4532 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2001 | 174 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 650 | 0.050 |
Why?
|
| Clinical Trials as Topic | 5 | 1993 | 3719 | 0.050 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2000 | 20 | 0.050 |
Why?
|
| Peritoneum | 1 | 2001 | 150 | 0.050 |
Why?
|
| Aftercare | 1 | 2002 | 259 | 0.050 |
Why?
|
| Hypoglycemia | 3 | 2008 | 213 | 0.050 |
Why?
|
| Sleep Deprivation | 1 | 2001 | 51 | 0.050 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2000 | 63 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2001 | 193 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2001 | 159 | 0.050 |
Why?
|
| Observer Variation | 3 | 2010 | 671 | 0.050 |
Why?
|
| Lipids | 2 | 1998 | 644 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 184 | 0.050 |
Why?
|
| Food Deprivation | 1 | 2000 | 47 | 0.050 |
Why?
|
| Rabbits | 2 | 2002 | 957 | 0.050 |
Why?
|
| Triiodothyronine | 1 | 2000 | 77 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2004 | 133 | 0.050 |
Why?
|
| Aorta | 1 | 2004 | 692 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 482 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2000 | 100 | 0.050 |
Why?
|
| Butyrates | 1 | 2000 | 57 | 0.050 |
Why?
|
| Inflammation | 3 | 2006 | 2522 | 0.040 |
Why?
|
| Leukocytes | 1 | 2002 | 422 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2010 | 2669 | 0.040 |
Why?
|
| Plethysmography | 2 | 2010 | 31 | 0.040 |
Why?
|
| Swine, Miniature | 2 | 1997 | 67 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2000 | 137 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 1999 | 20 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 846 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2002 | 478 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 589 | 0.040 |
Why?
|
| X Chromosome | 1 | 2000 | 339 | 0.040 |
Why?
|
| Hyaline Membrane Disease | 1 | 1998 | 11 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 1998 | 20 | 0.040 |
Why?
|
| Carbon Dioxide | 4 | 2009 | 313 | 0.040 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1998 | 18 | 0.040 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1998 | 20 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 1980 | 785 | 0.040 |
Why?
|
| Fats | 3 | 1988 | 16 | 0.040 |
Why?
|
| Mannitol | 1 | 1998 | 54 | 0.040 |
Why?
|
| Space Flight | 1 | 2001 | 158 | 0.040 |
Why?
|
| Drainage | 1 | 2001 | 416 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 966 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 1998 | 65 | 0.040 |
Why?
|
| Azathioprine | 1 | 1998 | 66 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 204 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2000 | 228 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 3 | 1989 | 46 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2001 | 422 | 0.040 |
Why?
|
| Iodocyanopindolol | 1 | 1997 | 2 | 0.040 |
Why?
|
| Permeability | 1 | 1998 | 167 | 0.040 |
Why?
|
| Pindolol | 1 | 1997 | 10 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2005 | 4078 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2010 | 6009 | 0.040 |
Why?
|
| Growth Disorders | 2 | 1992 | 218 | 0.040 |
Why?
|
| Exercise Test | 2 | 2011 | 312 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 1144 | 0.040 |
Why?
|
| Nervous System | 1 | 1998 | 165 | 0.040 |
Why?
|
| Hormones | 1 | 1999 | 266 | 0.040 |
Why?
|
| Medroxyprogesterone | 1 | 1997 | 14 | 0.040 |
Why?
|
| Peru | 3 | 1994 | 52 | 0.040 |
Why?
|
| Amenorrhea | 1 | 1997 | 34 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 1999 | 388 | 0.040 |
Why?
|
| Respiration | 3 | 2003 | 447 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1998 | 278 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 769 | 0.040 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 55 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1997 | 75 | 0.040 |
Why?
|
| Fasting | 1 | 1999 | 349 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2016 | 621 | 0.040 |
Why?
|
| Disease Progression | 3 | 2021 | 6682 | 0.040 |
Why?
|
| Privacy | 1 | 1997 | 34 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 1998 | 202 | 0.040 |
Why?
|
| Medical Records | 2 | 2009 | 415 | 0.040 |
Why?
|
| Mitral Valve | 2 | 2011 | 271 | 0.040 |
Why?
|
| Family Practice | 1 | 1997 | 125 | 0.040 |
Why?
|
| Directly Observed Therapy | 1 | 2016 | 21 | 0.040 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1997 | 121 | 0.040 |
Why?
|
| Weight Loss | 3 | 2005 | 627 | 0.040 |
Why?
|
| Hypothalamic Diseases | 1 | 1997 | 66 | 0.040 |
Why?
|
| Gene Expression | 2 | 2006 | 3570 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 749 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2000 | 549 | 0.030 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 1323 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2004 | 300 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 703 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 1998 | 259 | 0.030 |
Why?
|
| Isoniazid | 1 | 2016 | 63 | 0.030 |
Why?
|
| Mucositis | 1 | 2017 | 148 | 0.030 |
Why?
|
| Global Health | 1 | 2021 | 657 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 21445 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 3472 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2006 | 8865 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2001 | 1230 | 0.030 |
Why?
|
| Tuberculin Test | 1 | 2016 | 132 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2017 | 182 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 1270 | 0.030 |
Why?
|
| Triglycerides | 2 | 2011 | 603 | 0.030 |
Why?
|
| Prednisone | 1 | 1998 | 984 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 1996 | 103 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 1997 | 497 | 0.030 |
Why?
|
| Length of Stay | 2 | 2004 | 1900 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1997 | 273 | 0.030 |
Why?
|
| Rifampin | 1 | 2016 | 191 | 0.030 |
Why?
|
| Angioplasty, Balloon | 1 | 1996 | 183 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 700 | 0.030 |
Why?
|
| Random Allocation | 2 | 1988 | 703 | 0.030 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2016 | 174 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2000 | 1450 | 0.030 |
Why?
|
| Fetus | 2 | 1992 | 601 | 0.030 |
Why?
|
| Creatinine | 2 | 2007 | 531 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2017 | 333 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2009 | 473 | 0.030 |
Why?
|
| Probability | 2 | 2010 | 866 | 0.030 |
Why?
|
| Isoproterenol | 2 | 2000 | 127 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 71 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 131 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1998 | 739 | 0.030 |
Why?
|
| Heroin Dependence | 2 | 1985 | 54 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 96 | 0.030 |
Why?
|
| Platelet Count | 2 | 2005 | 490 | 0.030 |
Why?
|
| Equipment Design | 2 | 2009 | 1204 | 0.030 |
Why?
|
| Fatty Alcohols | 1 | 1993 | 10 | 0.030 |
Why?
|
| Infliximab | 1 | 2014 | 130 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 102 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 2016 | 318 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cholestasis | 2 | 2005 | 203 | 0.030 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 1997 | 324 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 1993 | 54 | 0.030 |
Why?
|
| Accelerometry | 1 | 2013 | 63 | 0.030 |
Why?
|
| Parents | 2 | 2017 | 998 | 0.030 |
Why?
|
| Haemophilus influenzae | 3 | 1988 | 144 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2001 | 1616 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 1993 | 61 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2012 | 9 | 0.030 |
Why?
|
| Fetal Movement | 1 | 1992 | 12 | 0.030 |
Why?
|
| Tocolytic Agents | 1 | 1992 | 7 | 0.030 |
Why?
|
| Mutation | 3 | 2008 | 15179 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 119 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 1993 | 123 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 1498 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7222 | 0.030 |
Why?
|
| Pulmonary Alveoli | 2 | 2010 | 208 | 0.030 |
Why?
|
| Lactation Disorders | 1 | 1992 | 8 | 0.030 |
Why?
|
| Malawi | 1 | 2014 | 378 | 0.030 |
Why?
|
| Myocarditis | 1 | 1995 | 190 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2008 | 1385 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2003 | 5637 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 1998 | 476 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1993 | 200 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1993 | 173 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 500 | 0.030 |
Why?
|
| Lipoprotein Lipase | 2 | 2003 | 52 | 0.030 |
Why?
|
| Parenteral Nutrition, Total | 3 | 1991 | 140 | 0.030 |
Why?
|
| United States | 5 | 2011 | 15433 | 0.030 |
Why?
|
| Diarrhea, Infantile | 2 | 1982 | 43 | 0.030 |
Why?
|
| Colectomy | 1 | 2014 | 288 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 426 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 1997 | 622 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 1375 | 0.030 |
Why?
|
| Airway Obstruction | 2 | 2011 | 261 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 590 | 0.030 |
Why?
|
| Mesalamine | 1 | 2011 | 9 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2008 | 732 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 546 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1991 | 115 | 0.020 |
Why?
|
| Dancing | 1 | 1991 | 22 | 0.020 |
Why?
|
| Behavior | 1 | 2011 | 103 | 0.020 |
Why?
|
| Mathematics | 3 | 1988 | 136 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1985 | 268 | 0.020 |
Why?
|
| Housing | 1 | 1991 | 61 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 176 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 7702 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 1997 | 792 | 0.020 |
Why?
|
| Biopsy | 2 | 2009 | 3443 | 0.020 |
Why?
|
| Syndrome | 2 | 2012 | 1351 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1997 | 581 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2011 | 91 | 0.020 |
Why?
|
| Sheep | 2 | 1988 | 258 | 0.020 |
Why?
|
| Urine | 3 | 2003 | 143 | 0.020 |
Why?
|
| Age Distribution | 2 | 2004 | 698 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 15 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2010 | 35 | 0.020 |
Why?
|
| Cricetinae | 2 | 2009 | 706 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2010 | 45 | 0.020 |
Why?
|
| Activin Receptors, Type II | 1 | 2010 | 38 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1997 | 918 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 3154 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 3869 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2013 | 6869 | 0.020 |
Why?
|
| Saliva | 3 | 2003 | 231 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2012 | 366 | 0.020 |
Why?
|
| Neoplasms | 2 | 2013 | 15193 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2010 | 112 | 0.020 |
Why?
|
| Glucose | 2 | 2009 | 1248 | 0.020 |
Why?
|
| Synkinesis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Sucrase | 1 | 2009 | 26 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 615 | 0.020 |
Why?
|
| Facial Asymmetry | 1 | 2009 | 22 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2006 | 6942 | 0.020 |
Why?
|
| Species Specificity | 2 | 2005 | 777 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 1989 | 15 | 0.020 |
Why?
|
| Bronchi | 1 | 2011 | 326 | 0.020 |
Why?
|
| Smiling | 1 | 2009 | 16 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2010 | 154 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 470 | 0.020 |
Why?
|
| Steroids | 1 | 2011 | 356 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 155 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 1538 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1988 | 684 | 0.020 |
Why?
|
| Muramidase | 3 | 1984 | 110 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 265 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 739 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2009 | 114 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 445 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 2489 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1995 | 1145 | 0.020 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2010 | 92 | 0.020 |
Why?
|
| Endorphins | 1 | 1988 | 21 | 0.020 |
Why?
|
| Nutrition Disorders | 3 | 1987 | 57 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 980 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1997 | 2054 | 0.020 |
Why?
|
| Ammonia | 1 | 1989 | 88 | 0.020 |
Why?
|
| Aged | 8 | 2011 | 70117 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 756 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 272 | 0.020 |
Why?
|
| Phosphorus | 2 | 1985 | 65 | 0.020 |
Why?
|
| Lactoferrin | 3 | 1984 | 81 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2009 | 6207 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 1391 | 0.020 |
Why?
|
| Neurocognitive Disorders | 1 | 1989 | 69 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1998 | 2315 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2008 | 115 | 0.020 |
Why?
|
| Thermodilution | 1 | 1988 | 15 | 0.020 |
Why?
|
| Acute Disease | 2 | 2012 | 2422 | 0.020 |
Why?
|
| Medicaid | 1 | 2011 | 279 | 0.020 |
Why?
|
| Indicator Dilution Techniques | 1 | 1988 | 22 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1988 | 48 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1989 | 253 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 484 | 0.020 |
Why?
|
| Bradycardia | 1 | 1988 | 70 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 376 | 0.020 |
Why?
|
| Smoking | 2 | 2011 | 2440 | 0.020 |
Why?
|
| Dobutamine | 1 | 1987 | 54 | 0.020 |
Why?
|
| Kidney | 2 | 2007 | 2146 | 0.020 |
Why?
|
| Manikins | 1 | 2009 | 137 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 1988 | 43 | 0.020 |
Why?
|
| Diuresis | 1 | 2007 | 63 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Cognition | 2 | 2012 | 968 | 0.020 |
Why?
|
| Hypotension | 1 | 2009 | 210 | 0.020 |
Why?
|
| CpG Islands | 1 | 2010 | 633 | 0.020 |
Why?
|
| Language Development | 1 | 2007 | 30 | 0.020 |
Why?
|
| Renin | 1 | 2007 | 92 | 0.020 |
Why?
|
| Aldosterone | 1 | 2007 | 72 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2009 | 557 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1988 | 103 | 0.020 |
Why?
|
| Dinoprost | 1 | 2007 | 33 | 0.020 |
Why?
|
| Video Recording | 1 | 2009 | 267 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2007 | 70 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 299 | 0.020 |
Why?
|
| Actuarial Analysis | 2 | 1988 | 159 | 0.020 |
Why?
|
| Meningitis | 1 | 1988 | 112 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 95 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 521 | 0.020 |
Why?
|
| Acidosis | 1 | 1988 | 116 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 793 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2011 | 649 | 0.020 |
Why?
|
| Trace Elements | 1 | 1987 | 33 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 4821 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 2803 | 0.020 |
Why?
|
| Body Fluids | 1 | 1988 | 125 | 0.020 |
Why?
|
| Sodium | 2 | 1985 | 353 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 573 | 0.020 |
Why?
|
| Paresis | 1 | 1986 | 54 | 0.020 |
Why?
|
| Time | 1 | 2007 | 178 | 0.020 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 20 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 272 | 0.020 |
Why?
|
| Base Sequence | 2 | 2003 | 4917 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2008 | 263 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 676 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 571 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2009 | 221 | 0.020 |
Why?
|
| Phenotype | 2 | 2013 | 6295 | 0.020 |
Why?
|
| Electrolytes | 1 | 2006 | 68 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 2843 | 0.020 |
Why?
|
| Deafness | 1 | 1986 | 82 | 0.020 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2005 | 7 | 0.020 |
Why?
|
| Cineangiography | 1 | 2005 | 22 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 2 | 2004 | 330 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2005 | 18 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2011 | 421 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2008 | 665 | 0.020 |
Why?
|
| Dopamine | 1 | 1987 | 312 | 0.020 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1985 | 21 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 1998 | 482 | 0.020 |
Why?
|
| Suction | 1 | 1985 | 104 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 521 | 0.020 |
Why?
|
| Survival Rate | 2 | 2009 | 12221 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 2403 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 6150 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1985 | 56 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2005 | 355 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 238 | 0.020 |
Why?
|
| Home Nursing | 1 | 1985 | 25 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2005 | 108 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2007 | 846 | 0.020 |
Why?
|
| Tablets | 1 | 1985 | 53 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 3 | 2004 | 2992 | 0.020 |
Why?
|
| Oxygen Isotopes | 3 | 1991 | 36 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 1988 | 354 | 0.020 |
Why?
|
| Magnesium | 1 | 1985 | 160 | 0.020 |
Why?
|
| Folic Acid Deficiency | 1 | 2005 | 54 | 0.020 |
Why?
|
| Methadone | 2 | 1985 | 195 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1988 | 280 | 0.020 |
Why?
|
| Milk | 1 | 1985 | 120 | 0.020 |
Why?
|
| Microspheres | 1 | 2005 | 210 | 0.020 |
Why?
|
| Electron Transport | 1 | 2004 | 79 | 0.020 |
Why?
|
| Tricuspid Valve | 1 | 1985 | 68 | 0.020 |
Why?
|
| Infant Welfare | 1 | 2004 | 19 | 0.020 |
Why?
|
| HIV Infections | 2 | 1998 | 2134 | 0.020 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 17 | 0.020 |
Why?
|
| Placenta | 1 | 2009 | 516 | 0.020 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 60 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 63 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2005 | 131 | 0.020 |
Why?
|
| Leucovorin | 1 | 2005 | 332 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 203 | 0.020 |
Why?
|
| Intelligence | 1 | 1985 | 126 | 0.020 |
Why?
|
| Polysomnography | 1 | 2005 | 155 | 0.020 |
Why?
|
| Cattle | 1 | 1985 | 783 | 0.010 |
Why?
|
| Azo Compounds | 1 | 2003 | 16 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1363 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 5767 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 103 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 238 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 652 | 0.010 |
Why?
|
| Isomerism | 1 | 2003 | 63 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2004 | 87 | 0.010 |
Why?
|
| Mice | 4 | 2006 | 34495 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 842 | 0.010 |
Why?
|
| Laparotomy | 1 | 2005 | 211 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2004 | 121 | 0.010 |
Why?
|
| Mucins | 1 | 2005 | 285 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 1062 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2004 | 131 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 1533 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 960 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1983 | 130 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2003 | 71 | 0.010 |
Why?
|
| Galactosidases | 1 | 1983 | 7 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 87 | 0.010 |
Why?
|
| Head | 1 | 1985 | 249 | 0.010 |
Why?
|
| Transcription Factors | 3 | 2003 | 5270 | 0.010 |
Why?
|
| Ligation | 1 | 2003 | 193 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2005 | 519 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 459 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 234 | 0.010 |
Why?
|
| Diet Surveys | 1 | 1983 | 117 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 974 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 2003 | 170 | 0.010 |
Why?
|
| Unemployment | 1 | 1982 | 31 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 3203 | 0.010 |
Why?
|
| Antarctic Regions | 1 | 2002 | 19 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 170 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 371 | 0.010 |
Why?
|
| Ireland | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 850 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1982 | 80 | 0.010 |
Why?
|
| Serotyping | 1 | 2002 | 166 | 0.010 |
Why?
|
| L-Selectin | 1 | 2002 | 34 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1983 | 237 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 1320 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 314 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1982 | 88 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 103 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10001 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 2002 | 98 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1982 | 55 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 486 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 1489 | 0.010 |
Why?
|
| HIV-1 | 1 | 2006 | 653 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 502 | 0.010 |
Why?
|
| Pericardiocentesis | 1 | 2001 | 33 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 418 | 0.010 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2002 | 106 | 0.010 |
Why?
|
| Educational Status | 1 | 1982 | 397 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2000 | 94 | 0.010 |
Why?
|
| Pressure | 1 | 2001 | 215 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1982 | 179 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2002 | 253 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 242 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2000 | 26 | 0.010 |
Why?
|
| Fatty Acid Synthases | 1 | 2000 | 24 | 0.010 |
Why?
|
| Microscopy | 1 | 2002 | 182 | 0.010 |
Why?
|
| Sterol Esterase | 1 | 2000 | 17 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2000 | 46 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 1620 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2000 | 29 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 45 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 549 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2000 | 20 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 461 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 1013 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2000 | 48 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2004 | 842 | 0.010 |
Why?
|
| Diastole | 2 | 1993 | 187 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2000 | 62 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2004 | 499 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2000 | 97 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 71 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2000 | 145 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 709 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 548 | 0.010 |
Why?
|
| Postprandial Period | 1 | 2000 | 85 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2000 | 74 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 1382 | 0.010 |
Why?
|
| Homeostasis | 1 | 1985 | 950 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 333 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2007 | 862 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2001 | 303 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 1008 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 591 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 299 | 0.010 |
Why?
|
| Erythema Multiforme | 1 | 1998 | 14 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 7548 | 0.010 |
Why?
|
| Breast | 1 | 1985 | 1344 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1982 | 442 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 4143 | 0.010 |
Why?
|
| Hydrops Fetalis | 1 | 1998 | 66 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 838 | 0.010 |
Why?
|
| Hematocrit | 1 | 1998 | 142 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2001 | 263 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1998 | 68 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 1983 | 394 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1983 | 526 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1506 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 5159 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2009 | 1375 | 0.010 |
Why?
|
| Bilirubin | 1 | 1998 | 221 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 752 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1998 | 460 | 0.010 |
Why?
|
| Neonatology | 1 | 1997 | 42 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 1997 | 74 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1997 | 209 | 0.010 |
Why?
|
| Professional Practice Location | 1 | 1996 | 16 | 0.010 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 1982 | 598 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 435 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 2961 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 29902 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 1259 | 0.010 |
Why?
|
| Pedigree | 1 | 2000 | 1890 | 0.010 |
Why?
|
| Life Tables | 1 | 1995 | 120 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 1033 | 0.010 |
Why?
|
| Health Resources | 1 | 1997 | 168 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6089 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1988 | 418 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1998 | 482 | 0.010 |
Why?
|
| Hospital Costs | 1 | 1997 | 228 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 1459 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 7551 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1994 | 116 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 1152 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 15862 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 2283 | 0.010 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 1984 | 24 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1998 | 764 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 5395 | 0.010 |
Why?
|
| Urea | 1 | 1994 | 290 | 0.010 |
Why?
|
| Zidovudine | 1 | 1993 | 40 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 224 | 0.010 |
Why?
|
| Syringes | 1 | 1993 | 42 | 0.010 |
Why?
|
| Milk Proteins | 2 | 1984 | 116 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1993 | 63 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1995 | 226 | 0.010 |
Why?
|
| Systole | 1 | 1993 | 196 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1993 | 254 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1992 | 241 | 0.010 |
Why?
|
| Critical Care | 1 | 1998 | 770 | 0.010 |
Why?
|
| Pneumonia | 1 | 1998 | 751 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1997 | 674 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 2195 | 0.010 |
Why?
|
| Morbidity | 1 | 1993 | 397 | 0.010 |
Why?
|
| Anorexia Nervosa | 1 | 1991 | 34 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1993 | 201 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1991 | 94 | 0.010 |
Why?
|
| Glutathione | 1 | 1993 | 368 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 5112 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1993 | 467 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1990 | 38 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1995 | 665 | 0.010 |
Why?
|
| Dihydropteridine Reductase | 1 | 1989 | 4 | 0.010 |
Why?
|
| Neopterin | 1 | 1989 | 13 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1989 | 50 | 0.010 |
Why?
|
| Emergency Service, Hospital | 2 | 1988 | 1148 | 0.010 |
Why?
|
| Hydrochloric Acid | 1 | 1988 | 19 | 0.010 |
Why?
|
| Asphyxia Neonatorum | 1 | 1988 | 15 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1989 | 145 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1993 | 830 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 2063 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 374 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1988 | 23 | 0.010 |
Why?
|
| Naloxone | 1 | 1988 | 82 | 0.010 |
Why?
|
| Body Fluid Compartments | 1 | 1988 | 21 | 0.000 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1986 | 26 | 0.000 |
Why?
|
| Plasma | 1 | 1988 | 158 | 0.000 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1987 | 101 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1986 | 131 | 0.000 |
Why?
|
| Follicular Phase | 1 | 1985 | 16 | 0.000 |
Why?
|
| Focal Infection | 1 | 1985 | 4 | 0.000 |
Why?
|
| Body Surface Area | 1 | 1985 | 42 | 0.000 |
Why?
|
| Ventilators, Mechanical | 1 | 1985 | 50 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 183 | 0.000 |
Why?
|
| Cephalometry | 1 | 1985 | 39 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1989 | 935 | 0.000 |
Why?
|
| Centrifugation | 1 | 1984 | 66 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1988 | 479 | 0.000 |
Why?
|
| Rats | 1 | 1993 | 6086 | 0.000 |
Why?
|
| Libraries | 1 | 1983 | 4 | 0.000 |
Why?
|
| Organization and Administration | 1 | 1983 | 8 | 0.000 |
Why?
|
| Methods | 1 | 1983 | 189 | 0.000 |
Why?
|
| Chromatography, Gas | 1 | 1983 | 39 | 0.000 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1983 | 208 | 0.000 |
Why?
|
| Nutritive Value | 1 | 1983 | 96 | 0.000 |
Why?
|
| Prenatal Care | 1 | 1985 | 325 | 0.000 |
Why?
|
| Fever | 1 | 1985 | 497 | 0.000 |
Why?
|
| Quality Control | 1 | 1983 | 457 | 0.000 |
Why?
|
| Zinc | 1 | 1983 | 188 | 0.000 |
Why?
|
| Antigens, Bacterial | 1 | 1984 | 354 | 0.000 |
Why?
|
| Hypothermia | 1 | 1982 | 59 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1985 | 554 | 0.000 |
Why?
|
| Kinetics | 1 | 1983 | 2049 | 0.000 |
Why?
|
| History, 20th Century | 1 | 1983 | 574 | 0.000 |
Why?
|
| Iron | 1 | 1983 | 376 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 11538 | 0.000 |
Why?
|